[at noodls] – CORONADO BIOSCIENCES ANNOUNCES SALE OF COMMON STOCK IN ITS AT-THE-MARKET PUBLIC OFFERING Burlington, MA – April 11, 2013 – Coronado Biosciences, Inc. (NASDAQ: CNDO), a biopharmaceutical company focused … moreView todays social media effects on CNDOView the latest stocks trending across Twitter. Click to view dashboardSee who Coronado is hiring next, click here to view […]
[at noodls] – CORONADO BIOSCIENCES ANNOUNCES INITIATION OF INVESTIGATOR-INITIATED STUDY EVALUATING TSO IN PSORIASIS Burlington, MA – February 25, 2013 – Coronado Biosciences, Inc. (NASDAQ: CNDO), a biopharmaceutical … moreView todays social media effects on CNDOView the latest stocks trending across Twitter. Click to view dashboardSee who Coronado is hiring next, click here to view […]
[at noodls] – CORONADO BIOSCIENCES SIGNS RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH FREIE UNIVERSITÄT BERLIN FOR SECRETORY PRODUCTS OF TRICHURIS SUIS Burlington, MA – February 22, 2013 – Coronado Biosciences, … moreView todays social media effects on CNDOView the latest stocks trending across Twitter. Click to view dashboardSee who Coronado is hiring next, click here to view […]
[at noodls] – Burlington, MA, January 2, 2013 (GLOBE NEWSWIRE) – Coronado Biosciences, Inc. (NASDAQ:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment … moreView todays social media effects on CNDOView the latest stocks trending across Twitter. Click to view dashboardSee who Coronado is hiring next, click here to view […]
[at noodls] – CORONADO BIOSCIENCES ACQUIRES TSO MANUFACTURING RIGHTS FROM OVAMED Burlington, MA – December 27, 2012 – Coronado Biosciences, Inc. (NASDAQ: CNDO), a biopharmaceutical company focused on the development … moreView todays social media effects on CNDOView the latest stocks trending across Twitter. Click to view dashboardSee who Coronado is hiring next, click here to view […]
[at noodls] – CORONADO INITIATES PHASE 1/2 TRIAL OF CNDO-109 ACTIVATED ALLOGENEIC NATURAL KILLER CELLS IN ACUTE MYELOID LEUKEMIA Burlington, MA – November 28, 2012 – Coronado Biosciences, Inc. (NASDAQ: CNDO), a biopharmaceutical … moreView todays social media effects on CNDOView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Burlington, MA – November 21, 2012 – Coronado Biosciences, Inc. (NASDAQ: CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune … moreView todays social media effects on CNDOView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Conference Call Scheduled for November 14, 2012 Burlington, MA – November 7, 2012 – Coronado Biosciences, Inc. (NASDAQ: CNDO), a biopharmaceutical company focused on the development of novel immunotherapy … moreView todays social media effects on CNDOView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Coronado Biosciences to Present at the Lazard Capital Markets 9th Annual Healthcare Conference Burlington, MA – November 6, 2012 – Coronado Biosciences, Inc. (NASDAQ: CNDO), a biopharmaceutical company … moreView todays social media effects on CNDOView the latest stocks trending across Twitter. Click to view dashboard […]
